Accenture Invests in Data Technology Company Inrupt
NEW YORK; March 29, 2022 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Inrupt, an enterprise software company focused on putting online personal data back in the power of users while also reinventing how businesses and governments manage digital data.
March 29, 2022
Accenture Invests in Extended Reality-based Immersive Learning Startup Talespin
NEW YORK; Feb. 17, 2022 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Talespin, a spatial computing company focused on workforce talent development and skills mobility. Talespin’s platform offers an end-to-end solution for creating, distributing and measuring the impact of immersive learning content.
February 17, 2022
Accenture Invests in Multicultural Media Technology Platform SwayBrand Through Accenture Ventures’ Black Founders Development Program
NEW YORK; Feb. 8, 2022 – Accenture (NYSE: ACN) has invested in Los Angeles-based SwayBrand, a multicultural media technology platform that helps brands connect with diverse influencers. This marks the first startup investment in North America made through the company’s Black Founders Development Program.
February 08, 2022
Accenture Makes Strategic Investment in Cloud-based Reality Data Solutions Provider Cintoo
NEW YORK and SOPHIA ANTIPOLIS, FRANCE; Jan. 27, 2022 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Cintoo, a provider of solutions used to better manage and leverage 3D data sourced from reality capture devices in the cloud.
January 27, 2022
Accenture Invests in Operational Resilience and Supply Chain Cybersecurity Company Interos
NEW YORK; Dec. 6, 2021 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Interos, an operational resilience and supply chain risk management company that uses machine learning to monitor global business relationships and identify risks.
December 06, 2021
Accenture Invests in Geneyx to Expand the Use of Genetic Data for Targeted and Personalized Therapeutics and Diagnostics
NEW YORK; Nov. 9, 2021 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd. (Geneyx), an Israel-based developer of genomic analysis and interpretation software. Geneyx helps improve patient outcomes associated with hereditary and rare diseases by providing disease-specific, clinically relevant insights around risk prediction, diagnosis, prognosis, and treatment for clinical and pharmaceutical organizations.
November 09, 2021